Honghu Zhu

#79 Qingchun Road
Hangzhou, 310003, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications

Clinical Characteristics, Treatment Patterns, and Prognosis of Central Nervous System Involvement in Multiple Myeloma: A Multicenter Retrospective Study From China.

Clinical Characteristics, Treatment Patterns, and Prognosis of Central Nervous System Involvement in Multiple Myeloma: A Multicenter Retrospective Study From China.

Journal: Cancer medicine
Published: October 12, 2025

Retraction Note: AMLnet, A deep-learning pipeline for the differential diagnosis of acute myeloid leukemia from bone marrow smears.

Retraction Note: AMLnet, A deep-learning pipeline for the differential diagnosis of acute myeloid leukemia from bone marrow smears.

Journal: Journal of hematology & oncology
Published: August 01, 2024

Homoharringtonine synergizes with venetoclax in early T cell progenitor acute lymphoblastic leukemia: Bench and bed.

Homoharringtonine synergizes with venetoclax in early T cell progenitor acute lymphoblastic leukemia: Bench and bed.

Journal: Med (New York, N.Y.)
Published: August 14, 2023

Advances in clinical studies of FLT3 inhibitors in acute myeloid leukemia.

Advances in clinical studies of FLT3 inhibitors in acute myeloid leukemia.

Journal: Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences
Published: May 18, 2023

Cellular hierarchy insights reveal leukemic stem-like cells and early death risk in acute promyelocytic leukemia.

Cellular hierarchy insights reveal leukemic stem-like cells and early death risk in acute promyelocytic leukemia.

Journal: Nature communications
Published: April 20, 2023

A combinatorial therapeutic approach to enhance FLT3-ITD AML treatment.

A combinatorial therapeutic approach to enhance FLT3-ITD AML treatment.

Journal: Cell reports. Medicine
Published: March 24, 2023

The clinical impact of IKZF1 mutation in acute myeloid leukemia.

The clinical impact of IKZF1 mutation in acute myeloid leukemia.

Journal: Experimental hematology & oncology
Published: February 17, 2023

AMLnet, A deep-learning pipeline for the differential diagnosis of acute myeloid leukemia from bone marrow smears.

AMLnet, A deep-learning pipeline for the differential diagnosis of acute myeloid leukemia from bone marrow smears.

Journal: Journal of hematology & oncology
Published: January 11, 2023

Targeting HDAC3 to overcome the resistance to ATRA or arsenic in acute promyelocytic leukemia through ubiquitination and degradation of PML-RARα.

Targeting HDAC3 to overcome the resistance to ATRA or arsenic in acute promyelocytic leukemia through ubiquitination and degradation of PML-RARα.

Journal: Cell death and differentiation
Published: July 01, 2022

15-days duration of venetoclax combined with azacitidine in the treatment of relapsed/refractory high-risk myelodysplastic syndromes: A retrospective single-center study.

15-days duration of venetoclax combined with azacitidine in the treatment of relapsed/refractory high-risk myelodysplastic syndromes: A retrospective single-center study.

Journal: Hematological oncology
Published: March 24, 2022

A Predictor Combining Clinical and Genetic Factors for AML1-ETO Leukemia Patients.

A Predictor Combining Clinical and Genetic Factors for AML1-ETO Leukemia Patients.

Journal: Frontiers in oncology
Published: September 25, 2021

A Novel NUP98/RARG Gene Fusion in Pediatric Acute Myeloid Leukemia Resembling Acute Promyelocytic Leukemia.

A Novel NUP98/RARG Gene Fusion in Pediatric Acute Myeloid Leukemia Resembling Acute Promyelocytic Leukemia.

Journal: Journal of pediatric hematology/oncology
Published: March 26, 2021
Showing 1-12 of 26

Last Updated: 09/26/2026